GV

Activity from announced rounds

Activity in this selectionalchip-technologies-007f7833
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$625M
2 disclosed · full round size, not this investor’s share

By stage

Series C+2

By primary sector

AI1
Biotech1

By country

United States2

Rounds

2 in this selection
Snorkel AI

Snorkel AI helps enterprises build expert-curated training data and benchmarks for advanced AI models and agents.

$350MSeries E
Participant
Encoded Therapeutics Inc.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

$275MSeries F
Lead